Episodes
Oct. 5, 2023
ICER’s Faux Updates
John O’Brien, President and CEO of the National Pharmaceutical Council, weighs in on ICER’s latest update that we are calling a “faux update”; The American Enterprise Institute has released its perspective on last year’s Inf…
None
Oct. 3, 2023
Hospital Price Transparency Noncompliance
Jonathan Weiss, Founder and CEO of HealthEngine, discusses why The No Surprise Act so far isn’t serving its intended purpose; a new secret shopper study found that hospitals are failing at price transparency for imaging serv…
None
Sept. 28, 2023
QALY Update
Bill Smith, Director of the Life Sciences Initiative at the Pioneer Institute, dives into the so-called update to ICER’s value assessment framework; Congresswoman Cathy McMorris Rodgers explained earlier this year why she wa…
None
Sept. 26, 2023
CMS Drug Price Negotiations
Kirsten Axelsen, Senior Policy Advisor at DLA Piper, says some of the fallout from CMS announcing price controls is already happening; the E&C Oversight and Investigations Subcommittee held a hearing on the IRA’s price-setti…
None
Sept. 21, 2023
Drug Supply Shortages
Gavin Clingham, Public Policy Director for the Alliance for Patient Access, discusses reasons behind drug supply shortages and some possible solutions; Patients Rising Now submitted questions to the E&C Oversight and Investi…
None
Sept. 19, 2023
The Value of New Medicines + Protecting Health Care for All
Peter Kolchinsky, Managing Partner at RA Capital Management, breaks down a new white paper with Entity rRisk that aims to get the math correct when measuring the value of new medicines; a new report says the HHS Office for C…
None
Sept. 14, 2023
Accelerated Approval Misconceptions + IRA Investing Impacts
Joseph Hammang, Ph.D., Partner at Vital Transformation Healthcare Consultancy, says some of the backlash against accelerated approval comes from those not informed on the process; Hammang also says impacts from the Inflation…
None
Sept. 12, 2023
IRA’s Impact on Drug Development
John Stanford with Incubate explains how the Inflation Reduction Act has already begun to deter investments in drug research and development; Patients Rising issues a statement calling for progress on several key healthcare …
None
Sept. 7, 2023
CMS Price Negotiations + Patient-Centered Outcomes
In the wake of Medicare’s announcement of the first 10 drugs subject to price negotiations, Patients Rising CEO Terry Wilcox outlines the need for greater patient involvement in this process; Taylor Schwartz of Avalere expla…
None
July 27, 2023
Biosimilars Reshape the Market
Avalere releases a study focused on ICER assessments and whether or not they take into account the patient experience when creating their reports; Wayne Winegarden, a Senior Fellow with the Pacific Research Institute explain…
None
July 25, 2023
Prior Authorization Consequences + Fast-Tracked FDA Approvals
MacKay Jimeson, Acting Executive Director of Patients Rising Now, wants lawmakers to stand behind the accelerated approval program; Jody Quinn, a patient from Massachusetts’ 13th congressional district who lives with psoriat…
None
July 20, 2023
Accelerated Approval on the Hill
MacKay Jimeson, Acting Executive Director of Patients Rising Now, previews Monday’s accelerated approval hill briefing, which is open for staff to attend; Mel Mann, the longest-living Gleevec patient, discusses how accelerat…
None
July 18, 2023
340B Fallout + Cancer Drug Shortages
Bill Smith, Senior Fellow at the Pioneer Institute, explains a ruling from the Supreme Court regarding the 340B program; Patients Rising Now’s briefing on Accelerated Approval will be held Monday, July 24th; Ted Okon, Execut…
None
July 13, 2023
AI Privacy Concerns + Accelerated Approval Benefits
Brett Meeks, Executive Director of the Health Innovation Alliance, is working to make sure everyone gets on the same page on the issue of health privacy and AI; The Pioneer Institute on Public Policy Research will host a web…
None
July 11, 2023
Alzheimer’s Breakthrough + Biosimilar Landscape
Sue Peschin, President and CEO of the Alliance for Aging Research, says Medicare coverage for Alzheimer’s drugs is something millions across the country truly care about as an election year nears; the Biden Administration is…
None
July 6, 2023
Home Health Hiccup + Rare Disease Priorities
Joanne Cunningham, CEO of the Partnership for Quality Home Healthcare, discusses the robust support for home health even as CMS aims to cut funding; Jeffrey Oldham, Director of State Government Relations and Advocacy for the…
None
June 29, 2023
Drug Supply Shortage Emergency + PASTEUR Act
Dr. Marion Mass, a pediatrician, has seen up close and personal what supply chain shortages can do; a news article from says that the proportion of oral cancer drugs that needed prior authorization increased from 53 percent…
None
June 27, 2023
RSV Vaccines + Patient Experience Data
Ronda Miller-Ernest, a Pediatric Nurse Practitioner for more than 30 years, discusses the importance of RSV vaccines and the Vaccines for Children Program in the wake of an ACIP meeting; the FDA has opened up its public comm…
None
June 22, 2023
Health Policies that Hurt Community Pharmacists
Anne Cassity, Senior Vice President of Government Affairs at the National Community Pharmacists Association, says community pharmacists are concerned about several PBM tactics that make delivering care more costly to them an…
None
June 15, 2023
Patients Call for PBM Reforms
Terry Wilcox, CEO of Patients Rising Now, outlines the top priorities for this year’s We the Patients Fly-In, including PBM reform; and Dorothea Lantz, a caregiver from Florida’s 27th Congressional District, says its importa…
None
June 13, 2023
Patients on Capitol Hill
Michael Riotto, a patient advocate from PA-01, says the QALY is top of mind for him as he attends the 2023 Patients Rising Now ‘We The Patients’ Fly-In; Tomiyo Williams, a patient advocate from GA-6, shares how step therapy …
None
June 8, 2023
CMS' New Power
The Patient Access and Affordability Project, a program of Patients Rising, releases principles for CMS to harness the power of patients as the agency implements the Inflation Reduction Act; CMS is foregoing some of the norm…
None
June 6, 2023
CMS Alzheimer's Decisions + No Data
Russ Paulsen, Chief Operating Officer for UsAgainstAlzheimer’s, explains how some recent coverage decisions from CMS are affecting thousands of patients a day; ACIP’s public comment period RSV vaccines is officially open; To…
None
June 1, 2023
UHC Prior Authorization Changes
Dr. Bruce Hennessy, a gastroenterologist with the American Society for Gastrointestinal Endoscopy, discusses UnitedHealthcare’s decision to require new prior authorization for 61 procedures, including colonoscopies. The Med…
None